Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Kramer

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|January 11, 2015
Identification of FAH domain-containing protein 1 (FAHD1) as oxaloacetate decarboxylaseHaymo Pircher, Susanne von Grafenstein, Thomas Diener, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and Minimal hERG InhibitionJohn G Cumming, Lukas Kreis, Holger Kühne, et al.
RSC Medicinal Chemistry|July 19, 2024
Geometric deep learning-guided Suzuki reaction conditions assessment for applications in medicinal chemistryKenneth Atz, David F Nippa, Alex T Müller, et al.
Light, Science & Applications|September 1, 2018
Cavity-assisted ultrafast long-range periodic energy transfer between plasmonic nanoantennasMartin Aeschlimann, Tobias Brixner, Mirko Cinchetti, et al.
Proteins|October 3, 2025
The CASP 16 Experimental Protein-Ligand DatasetsAndreas Tosstorff, Markus G Rudolph, Jörg Benz, et al.
Journal of Chemical Information and Modeling|February 14, 2025
The Need for Continuing Blinded Pose- and Activity Prediction BenchmarksChristian Kramer, John Chodera, Kelly L Damm-Ganamet, et al.
Journal of Medicinal Chemistry|September 29, 2017
Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA)Christian Kramer, Attilla Ting, Hao Zheng, et al.
Frontiers in Microbiology|March 7, 2017
Discovery and Characterization of Diazenylaryl Sulfonic Acids as Inhibitors of Viral and Bacterial NeuraminidasesAnja Hoffmann, Martina Richter, Susanne von Grafenstein, et al.
Journal of Pharmacological and Toxicological Methods|July 9, 2019
Safety screening in early drug discovery: An optimized assay panelStefanie Bendels, Caterina Bissantz, Bernhard Fasching, et al.
Nature Communications|November 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimizationDavid F Nippa, Kenneth Atz, Yannick Stenzhorn, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|January 11, 2015
Identification of FAH domain-containing protein 1 (FAHD1) as oxaloacetate decarboxylaseHaymo Pircher, Susanne von Grafenstein, Thomas Diener, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and Minimal hERG InhibitionJohn G Cumming, Lukas Kreis, Holger Kühne, et al.
RSC Medicinal Chemistry|July 19, 2024
Geometric deep learning-guided Suzuki reaction conditions assessment for applications in medicinal chemistryKenneth Atz, David F Nippa, Alex T Müller, et al.
Light, Science & Applications|September 1, 2018
Cavity-assisted ultrafast long-range periodic energy transfer between plasmonic nanoantennasMartin Aeschlimann, Tobias Brixner, Mirko Cinchetti, et al.
Proteins|October 3, 2025
The CASP 16 Experimental Protein-Ligand DatasetsAndreas Tosstorff, Markus G Rudolph, Jörg Benz, et al.
Journal of Chemical Information and Modeling|February 14, 2025
The Need for Continuing Blinded Pose- and Activity Prediction BenchmarksChristian Kramer, John Chodera, Kelly L Damm-Ganamet, et al.
Journal of Medicinal Chemistry|September 29, 2017
Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA)Christian Kramer, Attilla Ting, Hao Zheng, et al.
Frontiers in Microbiology|March 7, 2017
Discovery and Characterization of Diazenylaryl Sulfonic Acids as Inhibitors of Viral and Bacterial NeuraminidasesAnja Hoffmann, Martina Richter, Susanne von Grafenstein, et al.
Journal of Pharmacological and Toxicological Methods|July 9, 2019
Safety screening in early drug discovery: An optimized assay panelStefanie Bendels, Caterina Bissantz, Bernhard Fasching, et al.
Nature Communications|November 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimizationDavid F Nippa, Kenneth Atz, Yannick Stenzhorn, et al.
Pageof 7